FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Comer demands records after DC police leaders sidelined amid alleged crime data manipulation

Government Sues New York Times for Alleged Discrimination Against White Man

Obama’s Recent Political Moves Have Caused ‘Genuine Tension’ with Michelle

Trump’s grip on GOP tested in Indiana as primary battles target defiant Republicans

Trump-backed Vivek Ramaswamy wins Ohio GOP gubernatorial primary, will face Democrat Amy Acton

Trump posts mockup of ICE rebranded to ‘NICE’ after supporter’s suggestion

Cuba, China, and the pope: Key takeaways from Marco Rubio’s raucous White House press conference

Armed suspect who allegedly shot at Secret Service officers near White House identified as Texas man

Panicking Virginia Democrats Now Think Their Gerrymander Will Fail in Court, Triggering Infighting: Report

RFK Jr. unveils initiative targeting ‘overuse’ of psychiatric medications, especially among children

Chicago pol says Walgreens should be charged with ‘first-degree corporate abandonment’ over closure over theft

Rich Actress’s Virtue-Signaling Met Gala Stunt Falls Flat: ‘She’s Protesting Herself and Her Friends’

FBI nabs more than 350 alleged child sex abuse offenders

Survivors recount Islamist massacres of Congolese Christians in terrorism report

Fulton County fights DOJ bid for 2020 election workers’ personal data

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”